Clinical Trial Update: A Clinical Study on the Efficacy and Safety of Fruquintinib in Combination With PD-1 Monoclonal Antibody and Chidamide in Refractory MSS Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Fruquintinib in combination with a PD-1 monoclonal antibody and chidamide for refractory MSS metastatic colorectal cancer; cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Chidamide (chidamide)
• Fruquintinib (fruquintinib)
• PD-1 monoclonal antibody

Snippet

Sponsor: The First Hospital of Jilin University | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: RECRUITING